Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (Single-chain Triplebody) is designed to be expressed as a single chain with three scFv units, two distal binding sites for CD44 and a central site for CR3. It contains a His-tag at the C/N terminus for affinity purification. This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY